We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Open Orphan Plc | LSE:ORPH | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.00 | 9.50 | 10.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
15/9/2022 09:58 | Under Mifid 2 every trade has unique markers that report to the LSE who gave the order, for which account and who is the beneficial owner of the account. Big data analysis then links individuals together and trading patterns in different stocks. This has been around for 6 years now. Hugely intrusive I know but trust me all this data is available at a press of a button. | rock star | |
15/9/2022 09:26 | What everyone seems to be overlooking - there's more to insider trading than just company information. Having access to knowledge that an institution or fund is going to be taking or exiting a position, or knowledge that a company is talking about a potential financing is also insider trading (I bet there are more definitions). It, thus, doesn't necessarily mean that the company has done anything wrong even if it's their shares being dealt in a false market. | mauricemonkey | |
15/9/2022 08:35 | Unable to buy online for some time. Not sure why they do this. | ohsod1t | |
15/9/2022 08:06 | If connected to the Irish investors that used to be in oil stocks they operate with massive leverage. Would help explain the constant selling all the way down.margin calls? | rock star | |
15/9/2022 07:48 | Yes alot of guff about nowt. Co's share confidential info with 3rd parties all the time it's a BAU activity. You can't always control of that in confidence piece. | brianp14 | |
15/9/2022 07:44 | stock has been on decline for since March 2021 - yesterday was hardly that significant | sos100 | |
15/9/2022 07:42 | Good to have today's RNS 'for the record'. However, the English is apalling : ."The Company confirms that it was made aware of this allegation by, and at their request, is helping the relevant Irish authorities in respect of this allegation..." Really? | extrader | |
15/9/2022 07:33 | @Chica1 “sold half my holding yesterday” - was that the trade for 10 shares? | adorling | |
15/9/2022 07:28 | There has been a crew of dodgy Irish investors operating in the AIM market for years. Will it be the same gang that used to trade the AIM quoted oil stocks in US? They always had massive leverage. We will find out in fullness of time. | rock star | |
15/9/2022 07:20 | Big rise incoming after that sillu drop yesterday. Got limit order ready after that rns. So so undervalued | wololol | |
15/9/2022 07:13 | Looks like the man has been released without charge. | mark10101 | |
15/9/2022 07:09 | Big rise incoming after that RNS. Got limit order ready. | wololol | |
15/9/2022 00:13 | very interesting post marks cheers | manc10 | |
15/9/2022 00:00 | So our insider trader has been released without charge,with the file being prepared for director of public prosecution as per the national broadcaster RTE. Typical protocol for a white collar crime. | chica1 | |
15/9/2022 00:00 | Thanks for flagging this up Mark,nice to see something actually happening with Flu-v. I skim read through. conclusion that, "adjuvanted FLU-v vaccination induced cross-reactive cellular responses with cytotoxic capacity, further supporting the development of FLU-v as a broad-spectrum influenza vaccine." Hope you don't mind if I post this on the LSE board. Something else to focus on rather than todays news. | si derman | |
14/9/2022 20:50 | Looks like they have come out on Twitter now. It's all over the Irish news feeds. I wonder will they have an RNS tomorrow. | chica1 | |
14/9/2022 20:27 | What a gift to buy today will prove on a 1 year view there is a 100% upside IMO. £50m revenue, £20m cash as of September and profitable as well as a world leader position on Human Challenge Studies and working with 4 of the top 10 global pharma companies. The share price disconnect cannot last much longer. | adorling | |
14/9/2022 18:38 | My reply Louis, Why let it fester.. The share is collapsing because of this! Why not issue an RNS stating the facts you just told me,at least to stop the free fall Peter | chica1 | |
14/9/2022 18:25 | Just got the standard reply from IR. Peter, The Company is aware of the media report relating to the allegation of an incident of potential insider dealing in the Company’s shares by an unconnected private individual in 2020. The Company confirms that it was made aware of this allegation by, and at their request, is helping the relevant Irish authorities in respect of this allegation. The Board of Open Orphan is satisfied that there are no implications for the Company in the resolution of this allegation and confirms that no employee, executive, director or anyone connected with the Company had any involvement whatsoever in this matter nor are they suspected of any wrongdoing. Kind regards, Louis | chica1 | |
14/9/2022 18:17 | That's protocol.Thats what OO attorney's would have advised.Are you really so gullible? If you were CEO of a publicly traded company and someone has being flagged by the Central Bank and arrested by police for insider trading of your companies shares I'm sure you would inform shareholders.. | chica1 | |
14/9/2022 18:16 | That's protocol.Thats what OO attorney's would have advised.Are you really so gullible? If you were CEO of a publicly traded company and someone has being flagged by the Central Bank and arrested by police for insider trading of your companies shares I'm sure you would inform shareholders.. | chica1 | |
14/9/2022 18:06 | Bye bye chica1, enough is enough. | m5 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions